MedTrace Logo

Outcomes of Stem Cells for Cerebral Palsy

NCT02574923 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-05-07

No results posted yet for this study

Summary

The aim of this study is to assess the safety and effectiveness of autologous bone marrow mononuclear stem cells in patients with cerebral palsy.

Conditions

  • Cerebral Palsy

Interventions

BIOLOGICAL

Autologous Bone Marrow Mononuclear Cells

Transplantation of Autologous Bone Marrow Mononuclear Cells

Sponsors & Collaborators

  • Vinmec Healthcare System

    lead OTHER

Principal Investigators

  • Liem T Nguyen, MD., PhD. · Vinmec Healthcare System

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-05
Primary Completion
2018-03-30
Completion
2018-04-30

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02574923 on ClinicalTrials.gov